205 related articles for article (PubMed ID: 21148229)
1. Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial.
van den Bergh KA; Essink-Bot ML; Borsboom GJ; Scholten ET; van Klaveren RJ; de Koning HJ
Eur Respir J; 2011 Jul; 38(1):154-61. PubMed ID: 21148229
[TBL] [Abstract][Full Text] [Related]
2. Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON).
van den Bergh KA; Essink-Bot ML; Borsboom GJ; Th Scholten E; Prokop M; de Koning HJ; van Klaveren RJ
Br J Cancer; 2010 Jan; 102(1):27-34. PubMed ID: 19935789
[TBL] [Abstract][Full Text] [Related]
3. Impact of computed tomography screening for lung cancer on participants in a randomized controlled trial (NELSON trial).
van den Bergh KA; Essink-Bot ML; Bunge EM; Scholten ET; Prokop M; van Iersel CA; van Klaveren RJ; de Koning HJ
Cancer; 2008 Jul; 113(2):396-404. PubMed ID: 18484588
[TBL] [Abstract][Full Text] [Related]
4. High affective risk perception is associated with more lung cancer-specific distress in CT screening for lung cancer.
Bunge EM; van den Bergh KA; Essink-Bot ML; van Klaveren RJ; de Koning HJ
Lung Cancer; 2008 Dec; 62(3):385-90. PubMed ID: 18468717
[TBL] [Abstract][Full Text] [Related]
5. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
Horeweg N; Scholten ET; de Jong PA; van der Aalst CM; Weenink C; Lammers JW; Nackaerts K; Vliegenthart R; ten Haaf K; Yousaf-Khan UA; Heuvelmans MA; Thunnissen E; Oudkerk M; Mali W; de Koning HJ
Lancet Oncol; 2014 Nov; 15(12):1342-50. PubMed ID: 25282284
[TBL] [Abstract][Full Text] [Related]
6. Risk stratification based on screening history: the NELSON lung cancer screening study.
Yousaf-Khan U; van der Aalst C; de Jong PA; Heuvelmans M; Scholten E; Walter J; Nackaerts K; Groen H; Vliegenthart R; Ten Haaf K; Oudkerk M; de Koning H
Thorax; 2017 Sep; 72(9):819-824. PubMed ID: 28360223
[TBL] [Abstract][Full Text] [Related]
7. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON).
van Iersel CA; de Koning HJ; Draisma G; Mali WP; Scholten ET; Nackaerts K; Prokop M; Habbema JD; Oudkerk M; van Klaveren RJ
Int J Cancer; 2007 Feb; 120(4):868-74. PubMed ID: 17131307
[TBL] [Abstract][Full Text] [Related]
8. Limited contamination in the Dutch-Belgian randomized lung cancer screening trial (NELSON).
Baecke E; de Koning HJ; Otto SJ; van Iersel CA; van Klaveren RJ
Lung Cancer; 2010 Jul; 69(1):66-70. PubMed ID: 19801174
[TBL] [Abstract][Full Text] [Related]
9. Psychological outcomes of low-dose CT lung cancer screening in a multisite demonstration screening pilot: the Lung Screen Uptake Trial (LSUT).
Kummer S; Waller J; Ruparel M; Duffy SW; Janes SM; Quaife SL
Thorax; 2020 Dec; 75(12):1065-1073. PubMed ID: 33087548
[TBL] [Abstract][Full Text] [Related]
10. Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial.
Gareen IF; Duan F; Greco EM; Snyder BS; Boiselle PM; Park ER; Fryback D; Gatsonis C
Cancer; 2014 Nov; 120(21):3401-9. PubMed ID: 25065710
[TBL] [Abstract][Full Text] [Related]
11. Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch-Belgian randomised controlled lung cancer screening trial.
van der Aalst CM; van den Bergh KA; Willemsen MC; de Koning HJ; van Klaveren RJ
Thorax; 2010 Jul; 65(7):600-5. PubMed ID: 20627916
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial.
Horeweg N; van der Aalst CM; Thunnissen E; Nackaerts K; Weenink C; Groen HJ; Lammers JW; Aerts JG; Scholten ET; van Rosmalen J; Mali W; Oudkerk M; de Koning HJ
Am J Respir Crit Care Med; 2013 Apr; 187(8):848-54. PubMed ID: 23348977
[TBL] [Abstract][Full Text] [Related]
13. Generalisability of the results of the Dutch-Belgian randomised controlled lung cancer CT screening trial (NELSON): does self-selection play a role?
van der Aalst CM; van Iersel CA; van Klaveren RJ; Frenken FJ; Fracheboud J; Otto SJ; de Jong PA; Oudkerk M; de Koning HJ
Lung Cancer; 2012 Jul; 77(1):51-7. PubMed ID: 22459203
[TBL] [Abstract][Full Text] [Related]
14. Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval.
Yousaf-Khan U; van der Aalst C; de Jong PA; Heuvelmans M; Scholten E; Lammers JW; van Ooijen P; Nackaerts K; Weenink C; Groen H; Vliegenthart R; Ten Haaf K; Oudkerk M; de Koning H
Thorax; 2017 Jan; 72(1):48-56. PubMed ID: 27364640
[TBL] [Abstract][Full Text] [Related]
15. Long-term psychosocial outcomes of low-dose CT screening: results of the UK Lung Cancer Screening randomised controlled trial.
Brain K; Lifford KJ; Carter B; Burke O; McRonald F; Devaraj A; Hansell DM; Baldwin D; Duffy SW; Field JK
Thorax; 2016 Nov; 71(11):996-1005. PubMed ID: 27471048
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life and anxiety in the PAN-CAN lung cancer screening cohort.
Taghizadeh N; Tremblay A; Cressman S; Peacock S; McWilliams AM; MacEachern P; Johnston MR; Goffin J; Goss G; Nicholas G; Martel S; Laberge F; Bhatia R; Liu G; Schmidt H; Atkar-Khattra S; Tsao MS; Tammemagi MC; Lam SC;
BMJ Open; 2019 Jan; 9(1):e024719. PubMed ID: 30659040
[TBL] [Abstract][Full Text] [Related]
17. Psychosocial consequences in the Danish randomised controlled lung cancer screening trial (DLCST).
Rasmussen JF; Siersma V; Pedersen JH; Brodersen J
Lung Cancer; 2015 Jan; 87(1):65-72. PubMed ID: 25433982
[TBL] [Abstract][Full Text] [Related]
18. The impact of a lung cancer computed tomography screening result on smoking abstinence.
van der Aalst CM; van Klaveren RJ; van den Bergh KA; Willemsen MC; de Koning HJ
Eur Respir J; 2011 Jun; 37(6):1466-73. PubMed ID: 21148233
[TBL] [Abstract][Full Text] [Related]
19. Comparison Between Radiological Semantic Features and Lung-RADS in Predicting Malignancy of Screen-Detected Lung Nodules in the National Lung Screening Trial.
Li Q; Balagurunathan Y; Liu Y; Qi J; Schabath MB; Ye Z; Gillies RJ
Clin Lung Cancer; 2018 Mar; 19(2):148-156.e3. PubMed ID: 29137847
[TBL] [Abstract][Full Text] [Related]
20. Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial.
Horeweg N; van der Aalst CM; Vliegenthart R; Zhao Y; Xie X; Scholten ET; Mali W; Thunnissen E; Weenink C; Groen HJ; Lammers JW; Nackaerts K; van Rosmalen J; Oudkerk M; de Koning HJ
Eur Respir J; 2013 Dec; 42(6):1659-67. PubMed ID: 23845716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
